Join Macrowave Biotech at 2026 Global Nutraceutical Events!
As a global leading enterprise in the research and production of Omega-3 refined fish oil, we possess a world-class fully automated production facility.
When you choose Macrowave, you’re guaranteed more than a safe, pure Omega-3 ingredient,but also a professional testing lab, an excellent management system and a passionate team.
We offer varieties of concentration in health grade, feed grade, and in soft capsules.
As the world's leading producer of Omega-3 EPA/DHA, we have always carried out quality management to the highest standards to ensure that each batch of fish oil products meet the strict requirements of the international market. Our fish oil raw materials come from clean and pollution-free seas such as Peru and Chile, and our ...
Join Macrowave Biotech at 2026 Global Nutraceutical Events!
Macrowave is not just a Fish Oil Supplier; we are your strategic partner for Concentrated Omega-3 Raw Material. Leveraging an annual processing capacity of over 10,000 tons, we offer global Contract Manufacturers (CMs) three core advantages (3 Cs): Cost: Cost-leading pricing on high-potency Omega-3s, maximizing your COGS savings. Consistency: Unparalleled quality stability (EU/USP Certified) through our Refined Distillation Purification Technology. Capacity: Guaranteed supply security with flexible options, including TG/EE forms and Bulk Softgel services. Macrowave: Secure Your Supply. Sharpen Your Edge.
Feed grade fish oil, as a special type of fish oil specifically used for animal feed production, plays a crucial role in modern animal husbandry. It is mainly extracted from fatty fish and, after a series of refining processes, becomes a high-quality feed material that meets the nutritional needs of animals.
The popularity of fish oil supplements is steadily rising among health-conscious consumers.
We are excited to share that Macrowave Bio will be attending Vitafoods Europe 2025, held from Barcelona.
Study published in Mayo Clinic Proceedings supports multiple cardiovascular risk reductions